Search

everythinglearnresearchcommunity

for

Search:↓

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Oral contraceptives may cause hair loss in women.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.